Alpha-particle radioimmunotherapy with astatine-211 and bismuth-213.
Lucignani
Giovanni
G
Institute of Radiological Sciences, University of Milan, Unit of Nuclear Medicine, Hospital San Paolo, Via Antonio di Rudinì 8, Milan, Italy. giovanni.lucignani@unimi.it
D000512:Alpha Particles / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology; D001246:Astatine / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000532:radiotherapy; D045744:Cell Line, Tumor; D005260:Female; D006801:Humans; D051379:Mice; D010051:Ovarian Neoplasms / Q000532:radiotherapy; D016499:Radioimmunotherapy / Q000379:methods*; D011868:Radioisotopes
D000970:Antineoplastic Agents; D011868:Radioisotopes; D001729:Bismuth; D001246:Astatine